Very exiting board news for Acarix

It was a pleasure for me Tuesday to beeing able to present and getting approved a proposal at the annual general meeting regarding the new board in Acarix.
Getting such heavy profiles as Ken Nelson and Dr. Tony Das on the board is a very strong signal to the cardiovascular space and to the market, that the CADScor system has something importtant to offer. With their deep expertice and impressing track record, they will play an important role in assisting the new CEO and the rest of the board to take Acarix to the next level.
With this team in place, we at LSIF strongly believe, Acarix is well positioned to get the tracktion, this fantastic product deserves, and we are delighted to have been part of the process to form the board going forward.